Pakistanis angry over detentions in Times Sq. case Monday, May 24, 2010
ISLAMABAD – Relatives of three men detained by Pakistan for alleged links to the suspect in the attempted Times Square bombing say the men are innocent.
They
AFP - Thursday, August 6TAIPEI (AFP) - - Taiwan's Beijing-friendly government on Wednesday denied boycotting an Australian film festival amid a row over the e
BERLIN (Reuters) - Chancellor Angela Merkel suffered a double blow on Thursday as a senior party ally in east German
Minister seeks closure of anti-Berlusconi websites Wednesday, December 16, 2009
ROME (AFP) - – The Italian government moved Tuesday to close down Internet sites encouraging further violence against Prime Minister Silvio Berlusconi, who
By ELAINE KURTENBACH,AP Business Writer AP - Wednesday, March 18SHANGHAI - Asia's stock market rally seemed to be running out of steam Wednesday, despite an
Edition:
U.S.
Africa
Arabic
Argentina
Brazil
Canada
China
France
Germany
India
Italy
Japan
Latin America
Mexico
Russia
Spain
United Kingdom
Home
Business
Business Home
Economy
Technology
Media
Small Business
Legal
Deals
Earnings
Social Pulse
Business Video
The Freeland File
Aerospace & Defense
Markets
Markets Home
U.S. Markets
European Markets
Asian Markets
Global Market Data
Indices
M&A
Stocks
Bonds
Currencies
Commodities
Futures
Funds
peHUB
World
World Home
U.S.
Brazil
China
Euro Zone
Japan
Mexico
Russia
India Insight
World Video
Reuters Investigates
Decoder
Politics
Politics Home
Election 2012
Campaign Polling
Political Punchlines
Supreme Court
Politics Video
Tech
Technology Home
MediaFile
Science
Tech Video
Tech Tonic
Social Pulse
Opinion
Opinion Home
Chrystia Freeland
John Lloyd
Felix Salmon
Jack Shafer
David Rohde
Bernd Debusmann
Nader Mousavizadeh
Lucy P. Marcus
David Cay Johnston
Bethany McLean
Anatole Kaletsky
Edward Hadas
Hugo Dixon
Ian Bremmer
Lawrence Summers
Susan Glasser
The Great Debate
Steven Brill
Jack & Suzy Welch
Frederick Kempe
Christopher Papagianis
Mark Leonard
Reihan Salam
Breakingviews
Equities
Credit
Private Equity
M&A
Macro & Markets
Politics
Breakingviews Video
Money
Money Home
Tax Break
Lipper Awards 2012
Global Investing
MuniLand
Unstructured Finance
Linda Stern
Mark Miller
John Wasik
James Saft
Analyst Research
Alerts
Watchlist
Portfolio
Stock Screener
Fund Screener
Personal Finance Video
Money Clip
Investing 201
Life
Health
Sports
Arts
Faithworld
Business Traveler
Entertainment
Oddly Enough
Lifestyle Video
Pictures
Pictures Home
Reuters Photographers
Full Focus
Video
Reuters TV
Reuters News
Article
Comments (0)
Slideshow
Full Focus
Editor's choice
Our best photos from the last 24 hours. Full Article
Images of August
Follow Reuters
Facebook
Twitter
RSS
YouTube
Read
Italian magazine plans 26-page special on topless Kate photos
|
15 Sep 2012
Chicago teachers fear wave of school closings after strike
15 Sep 2012
Sudan rejects U.S. request to send Marines to guard embassy
15 Sep 2012
Chicago teachers rally after tentative labor deal
15 Sep 2012
Iran on brink of nuclear bomb in six-seven months: Netanyahu
|
1:52pm EDT
Discussed
286
U.S. ambassador to Libya, three staff killed in rocket attack
185
Insight: GM’s Volt – The ugly math of low sales, high costs
162
Egyptians angry at film scale U.S. embassy walls
Sponsored Links
Pictures
Reuters Photojournalism
Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography. See more | Photo caption
Dancing horses
Lipizzaner horses spend their summers in the Austrian mountains, before returning to train as dancing horses. Slideshow
Will & Kate's Asia tour
The royal couple are on a nine-day tour of Southeast Asia and the South Pacific. Slideshow
China struggles to cure the violent ills of health system
Tweet
Share this
Email
Print
Related News
Insight: AIDS science leaping ahead, but will the money follow?
Thu, Sep 6 2012
Alarming levels of drug-resistant TB found worldwide
Thu, Aug 30 2012
Special Report: China's "wild east" drug store
Tue, Aug 28 2012
U.S. health panel likely to make HIV tests routine
Sun, Aug 19 2012
Analysis & Opinion
A tale of two healthcare plans
Related Topics
World »
Health »
1 of 2. A man uses a stick to hold up a drip for his granddaughter, who is held by her mother, as the girl receives an intravenous injection at a hospital in Hefei, Anhui province, in this November 30, 2011 file picture.
Credit: Reuters/Stringer/Files
By Tan Ee Lyn and Hui Li
GUANGZHOU/BEIJING |
Sun Sep 16, 2012 5:27pm EDT
GUANGZHOU/BEIJING (Reuters) - Beijing is struggling to deal with an increasingly violent flashpoint of social unrest in its healthcare system, as its latest bid to cut costs is failing to ease tensions among millions of people who cannot afford basic treatment.
Violent attacks directed at hospital doctors and other healthcare workers in the form of beatings, threats, kidnappings, verbal abuse and even killings soared in recent years to 17,243 cases in 2010, alarming central policymakers who regard China's overhaul of its lumbering public healthcare system a top national priority.
Critics say China's efforts to cut treatment costs in public hospitals and defuse tensions do not go far enough and show little sign of reversing the violence of angry sufferers.
"The government is very worried about violence against doctors, especially when a few doctors and healthcare workers were attacked earlier this year. Some hospitals now have guards guarding them," said a health official in southern Guangdong province, speaking on condition of anonymity because of the sensitivity of the issue.
"It's a top priority to stop these things from happening," said the source, who works in hospital administration.
In July, the ruling Communist Party sought to make treatment more affordable by looking to ban an age-old practice among public hospitals of marking up drugs prices by 15 percent, a practice the government allowed to flourish after it wound back subsidies for public hospitals from the 1950s.
The ban applies to 300 county hospitals under a pilot project. But a patients' group and senior Chinese health officials say the measure, even if implemented nationwide, does not make medicines substantially more affordable.
Instead, they say Beijing must tackle the far fatter markups enjoyed by drug distributors, a web of middlemen who inflate prices by 40 percent and sometimes by several-fold to levels that are beyond the reach of many ordinary Chinese.
This is a "bigger problem", said Liao Xinbo, deputy director general for health in southern Guangdong province.
"Nothing is being done to change this," said Liao, who is about to publish his second book taking a critical look at China's healthcare reforms.
PAYING THE BILL
One Chinese struggling to meet medical bills is Xu Shiding, who needs weekly injections that each cost more than 1,300 yuan ($210) to control chronic hepatitis C.
The gold miner in China's northwestern region of Xinjiang has to pay out of his own pocket for one or two injections each month. He has state health insurance, but his cover is limited.
With monthly income of 2,600 yuan, he has been forced to borrow money from his family, he said.
"I have even become a boyfriend of a wealthy married woman," said Xu, sobbing at times, as he alluded to how he needs his mistress's financial support to pay for his treatment. Left untreated, such patients may end up with liver cirrhosis and even cancer.
The average cost of a single hospital admission in China is roughly the same as average annual income, a 2008 paper published in The Lancet said. For the lowest fifth of income earners, it is more than twice average annual earnings, the paper said.
REFORMS MEET VESTED INTERESTS
China's healthcare spending is set to grow to $1 trillion by 2020 from $357 billion in 2011, consultancy McKinsey & Company said in a report in July.
Embedded in China's healthcare system are strong vested interests: tens of thousands of drug-makers and distributors supporting workers and their families and local governments that depend on tax revenues from these companies.
In China's fragmented healthcare sector, a batch of drugs can go through two, even three layers of distributors before ending up at a hospital. It is not uncommon to have a distributor servicing only one hospital. Each distributor takes a cut and pays doctors and advertisers to promote its sales.
Beijing has a blueprint for reforming distribution but healthcare experts say it is bound to face fierce resistance among provincial authorities already worried about tax revenues as economic growth slows down.
"There are literally thousands of distributors and they tend to be localized ... China wants to consolidate them. But every time a small company disappears, it is the taxes, jobs that go away," said Franck Le Deu, partner and head of Greater China healthcare at McKinsey & Company in Shanghai.
"Therefore, the consolidation process faces resistance."
In addition, some of the companies involved in the distribution chain are state-owned enterprises, which will resist change, said Li Renbing, a lawyer representing the China Patients' Rights League Project Group.
"Can the government cut them out completely? These enterprises have to survive, which is why this middle section (of distributors) is preserved," Li said.
Still, some major distributors are not resistant to changing the current system. Beijing is starting to set floor and ceiling prices for state-subsidized medicines, which they say could help deliver more affordable healthcare.
"When both the floor and ceiling prices are controlled, then whoever has a better and more trusted brand will gain," said Jia Zhongxin, chief operating officer for Sihuan Pharmaceutical Holdings Group Ltd, the eighth largest drugmaker and distributor in China by market share.
Still, critics say even that idea won't work because hospitals can find other ways to increase costs for patients, such as by encouraging tests that may not be necessary, and sophisticated and costly treatment.
While Beijing wound back subsidies from the 1950s, it allowed hospitals to mark up drug prices to alleviate budget pressure, effectively passing these costs on to patients.
Drug distributors then moved into the picture from the 1980s when China opened up its economy, pushing prices even higher.
Critics say doctors have an incentive to earn commissions on prescribing drugs because by international standards their salaries are low, ranging from 4,000 yuan ($628) to 10,000 yuan ($1,570) a month.
"Within this space, salesmen push for sales, offering commissions to doctors if they prescribe more of certain drugs. Prices go up. Hospitals prescribe more expensive drugs because the cuts and the markups from them are higher," said Liao, the Guangdong province health official.
"Everyone profits from this big mark-up. Who suffers? The common people. Whoever has to consume the drug suffers." ($1 = 6.3264 Chinese yuan)
(Additional Reporting by Donny Kwok in Hong Kong: Editing by Neil Fullick)
World
Health
Related Quotes and News
Company
Price
Related News
Tweet this
Link this
Share this
Digg this
Email
Reprints
We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (0)
Be the first to comment on reuters.com.
Add yours using the box above.
Edition:
U.S.
Africa
Arabic
Argentina
Brazil
Canada
China
France
Germany
India
Italy
Japan
Latin America
Mexico
Russia
Spain
United Kingdom
Back to top
Reuters.com
Business
Markets
World
Politics
Technology
Opinion
Money
Pictures
Videos
Site Index
Legal
Bankruptcy Law
California Legal
New York Legal
Securities Law
Support & Contact
Support
Corrections
Connect with Reuters
Twitter
Facebook
LinkedIn
RSS
Podcast
Newsletters
Mobile
About
Privacy Policy
Terms of Use
AdChoices
Copyright
Our Flagship financial information platform incorporating Reuters Insider
An ultra-low latency infrastructure for electronic trading and data distribution
A connected approach to governance, risk and compliance
Our next generation legal research platform
Our global tax workstation
Thomsonreuters.com
About Thomson Reuters
Investor Relations
Careers
Contact Us
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.